100700 — Sewoon Medical Co Income Statement
0.000.00%
- KR₩105bn
- KR₩22bn
- KR₩60bn
- 76
- 77
- 16
- 60
Annual income statement for Sewoon Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63,729 | 62,579 | 60,116 | 68,247 | 60,151 |
Cost of Revenue | |||||
Gross Profit | 23,725 | 25,057 | 22,220 | 27,557 | 22,188 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49,568 | 47,196 | 47,931 | 51,327 | 48,774 |
Operating Profit | 14,161 | 15,383 | 12,185 | 16,920 | 11,377 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13,336 | 16,626 | 13,629 | 19,298 | 15,621 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10,555 | 12,762 | 10,639 | 15,474 | 12,575 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 10,496 | 12,282 | 10,406 | 14,957 | 12,163 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10,496 | 12,282 | 10,406 | 14,957 | 12,163 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 240 | 284 | 240 | 345 | 276 |
Dividends per Share |